Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease
Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease have?
Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease has 10 citations in the OpenAlex counts ScholarIQ stores.
When was Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease published?
Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease has 2023 year in the ScholarIQ index.
What is the open-access status of Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease?
Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease has gold oa status in the ScholarIQ index.
What is the DOI of Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease?
The DOI for Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease is on the source record.
What is the PMID of Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease?
The PMID for Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease is on the source record.
What is the OpenAlex record for Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease?
The OpenAlex for Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease is on the source record.